Bharat Biotech Set To Begin Phase 1 Of Clinical Trials For Intranasal Covid-19 Vaccine; Know All About It

12:22 AM
Hyderabad- based pharma company Bharat Biotech will begin trials of its intranasal Covid-19 vaccine. The company has also sought approval for the emergency use of Covaxin.

from covid-19 https://ift.tt/3oND72P

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.